Patents by Inventor Beata Nowicka-Sans

Beata Nowicka-Sans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS
    Publication number: 20230295220
    Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.
    Type: Application
    Filed: December 16, 2022
    Publication date: September 21, 2023
    Inventors: Jie CHEN, Yan Chen, Ira B. Dicker, Richard A. Hartz, Nicholas A. Meanwell, Beata Nowicka-Sans, Alicia Regueiro-ren, Sing-Yeun Sit, Ny Sin, Jacob Swidorski, Brian Lee Venables
  • C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS
    Publication number: 20210323997
    Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.
    Type: Application
    Filed: June 9, 2021
    Publication date: October 21, 2021
    Inventors: Jie CHEN, Yan Chen, Ira B. Dicker, Richard A. Hartz, Nicholas A. Meanwell, Beata Nowicka-Sans, Alicia Regueiro-Ren, Sing-Yuen Sit, Ny Sin, Jacob Swidorski, Brian Lee Venables
  • C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
    Patent number: 11084845
    Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: August 10, 2021
    Assignee: ViiV HEALTHCARE UK (NO. 5) LIMITED
    Inventors: Jie Chen, Yan Chen, Ira B. Dicker, Richard A. Hartz, Nicholas A. Meanwell, Beata Nowicka-Sans, Alicia Regueiro-Ren, Sing-Yuen Sit, Ny Sin, Jacob Swidorski, Brian Lee Venables
  • C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS
    Publication number: 20190359647
    Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.
    Type: Application
    Filed: August 7, 2019
    Publication date: November 28, 2019
    Inventors: Jie CHEN, Yan Chen, Ira B. Dicker, Richard A. Hartz, Nicholas A. Meanwell, Beata Nowicka-Sans, Alicia Regueiro-Ren, Sing-Yuen Sit, Ny Sin, Jacob Swidorski, Brian Lee Venables
  • C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
    Patent number: 10421774
    Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: September 24, 2019
    Assignee: ViiV HEALTHCARE UK (NO.5) LIMITED
    Inventors: Jie Chen, Yan Chen, Ira B. Dicker, Richard A. Hartz, Nicholas A. Meanwell, Beata Nowicka-Sans, Alicia Regueiro-Ren, Sing-Yuen Sit, Ny Sin, Jacob Swidorski, Brian Lee Venables
  • C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS
    Publication number: 20190031709
    Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.
    Type: Application
    Filed: February 2, 2017
    Publication date: January 31, 2019
    Inventors: Jie CHEN, Yan CHEN, Ira B. DICKER, Richard A. HARTZ, Nicholas A. MEANWELL, Beata NOWICKA-SANS, Alicia REGUEIRO-REN, Sing-Yuen SIT, Ny SIN, Jacob SWIDORSKI, Brian Lee VENABLES
  • Methods of treating HIV infection
    Patent number: 7776863
    Abstract: The invention encompasses pharmaceutical compositions and methods for using Compound 1 in combination with other agents for treating patients with AIDS or HIV infection.
    Type: Grant
    Filed: February 24, 2005
    Date of Patent: August 17, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Pin-Fang Lin, Beata Nowicka-Sans, Gregory Yamanaka
  • Methods of treating HIV infection
    Publication number: 20050215545
    Abstract: The invention encompasses pharmaceutical compositions and methods for using Compound 1 in combination with other agents for treating patients with AIDS or HIV infection.
    Type: Application
    Filed: February 24, 2005
    Publication date: September 29, 2005
    Inventors: Pin-Fang Lin, Beata Nowicka-Sans, Gregory Yamanaka
  • Methods of treating HIV infection
    Publication number: 20050215544
    Abstract: The invention encompasses pharmaceutical compositions and methods for using Compound 1 in combination with other agents for treating patients with AIDS or HIV infection.
    Type: Application
    Filed: February 18, 2005
    Publication date: September 29, 2005
    Inventors: Pin-Fang Lin, Beata Nowicka-Sans, Gregory Yamanaka
  • Methods of treating HIV infection
    Publication number: 20050215543
    Abstract: The invention encompasses pharmaceutical compositions and methods for treating AIDS and HIV infection employing Compound 1.
    Type: Application
    Filed: February 14, 2005
    Publication date: September 29, 2005
    Inventors: Pin-Fang Lin, Beata Nowicka-Sans, Gregory Yamanaka